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Male	 32	(65.3)	 60	(60.6)	 0.579	
Mean	age	(SD)	 60.33	(14.2)	 60.61	(16.3)	 0.714	
Risk	factors	 	 	 	
Treatment	delay	>48	hours*		 9	(22.0)	 36	(43.4)	 0.020	




Community	acquired	bacteremia	 31	(63.3)	 88	(88.9)	 <0.001	
Foreign	body	material	present	 15	(30.6)	 46	(46.5)	 0.065	
Infectious	disease	specialist	consultation	 30	(61.2)	 89	(89.9)	 <0.001	
Echocardiograpy§		 20	(40.8)	 90	(90.9)	 <0.001	
Charlson	comorbidity	score	(SD)	 5.12	(3.4)	 4.43	(2.9)	 0.314	
Intensive	care	admission	 14	(28.6)	 26	(26.3)	 0.766	
Three‐month	outcome	 	 	 	
							Death	 16	(32.7)	 12	(12.1)	 0.003	




























Male		 67	(60.8)	 19	(67.9)	 0.490	 	 	
Echocardiography	
performed		
91	(75.8)	 19	(67.9)	 0.384	 	 	
Composite	risk	score*	
(SD)	
1.65	(1.14)	 1.93	(1.09)	 0.067	 0.052	 1.537	(0.997‐2.371)	
Charlson	comorbidity	
score	(SD)	
4.24	(2.90)	 6.46	(3.49)	 0.002	 0.003	 1.254	(1.078‐1.457)	
18F‐FDG‐PET/CT	
performed		
87	(72.5)	 12	(42.9)	 0.003	 0.005	 0.204	(0.066‐0.624)	
ID	specialist	
consultation	
99	(82.5)	 20	(71.4)	 0.184	 0.786	 0.851	(0.266‐2.721)	
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